Inventor, Researcher, Medical Device Manufacturer Executive
BOSTON, Mass. (June 14, 2021) – Myomo, Inc. (NYSE American: MYO) (“Myomo” or the “Company”), a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper-limb paralysis, today announced that its shareholders, at its meeting on June 9, 2021, elected Milton Morris, PhD, as Director. Dr. Morris was elected to serve as a Class I director, with an initial term of three years until the 2024 annual meeting of stockholders. Read more.